P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 52, 2005, Pages 19138-19143

  Arthur, David B ^a   Akassoglou, Katerina ^a   Insel, Paul A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Neurotrophin signaling; P2Y2; Tyrosine receptor kinase A

Indexed keywords

ADENOSINE 5' O (3 THIOTRIPHOSPHATE); GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHOGEN; NERVE GROWTH FACTOR; NEUROMODULIN; NEUROTROPHIN; NUCLEOTIDE; PROTEIN TYROSINE KINASE A; PURINE P2Y2 RECEPTOR; RECEPTOR; SMALL INTERFERING RNA; ADENOSINE 5'-O-(3-THIOTRIPHOSPHATE); ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PURINE P2 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL GANGLION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL STRAIN; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SIGNAL TRANSDUCTION; TIME;

ANIMALIA;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DIFFERENTIATION; ENZYME INHIBITORS; GAP-43 PROTEIN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; NERVE GROWTH FACTOR; NEURONS; PC12 CELLS; RATS; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SCIATIC NERVE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 30044441160     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0505913102     Document Type: Article

References (58)

1. Yamamoto, N., Tamada, A. & Murakami, F. (2002) Prog. Neurobiol. 68, 393-407.
2. Terenghi, G. (1999) J. Anat. 194, 1-14.
3. Boglari, G. & Szeberenyi, J. (2001) Eur. J. Neurosci. 14, 1445-1454.
4. Gavazzi, I. & Cowen, T. (1996) J. Auton. Nerv. Syst. 58, 1-10.
5. Chuang, H. H., Prescott, E. D., Kong. H., Shields, S., Jordt, S. E., Basbaum, A. I., Chao, M. V. & Julius, D. (2001) Nature 411, 957-962.
6. Chao, M. V. (2003) Neuron 39, 1-2.
7. Yano, H. & Chao, M. V. (2004) J. Neurobiol. 58, 244-257.
8. Chi, L., Li, Y., Stehno-Bittel, L., Gao, J., Morrison, D. C., Stechschulte, D. J. & Dileepan, K. N. (2001) J. Interferon Cytokine Res. 21, 231-240.
9. Neary, J. T., Rathbone, M. P., Cattabeni, F., Abbracchio, M. P. & Burnstock, G. (1996) Trends Neurosci. 19, 13-18.
10. Rathbone, M. P., Middlemiss, P. J., Gysbers, J. W., Andrew, C., Herman, M. A., Reed, J. K., Ciccarelli, R., Di Iorio, P. & Caciagli, F. (1999) Prog. Neurobiol. 59, 663-690.
11. Lechner, S. G., Dorostkar, M. M., Mayer, M., Edelbauer, H., Pankevyeh, H. & Boehm, S. (2004) Eur. J. Neurosci. 20, 2917-2928.
12. Neary, J. T. & Zhu, Q. (1994) NeuroReport 5, 1617-1620.
13. Fields, R. D. & B. Stevens. (2000) Trends Neurosci. 23, 625-633.
14. Burnstock, G. & Knight, G. E. (2004) Int. Rev. Cytol. 240, 31-304.
15. Khakh, B. S., Burnstock, G., Kennedy, C., King, B. F., North, R. A., Seguela, P., Voigt, M. & Humphrey, P. P. A. (2001) Pharmacol. Rev. 53, 107-118.
16. Cockayne, D. A., Hamilton, S. G., Zhu, Q. M., Dunn, P. M., Zhong, Y., Novakovic, S., Malmberg, A. B., Cain, G., Berson, A. & Kassotakis, L. (2000) Nature 407, 1011-1015.
17. Gourine, A. V., Llaudet, E., Dale, N. & Spyer, K. M. (2005) Nature 436, 108-111.
18. Boehm, S. (2003) Br. J. Pharmacol. 138, 1-3.
19. Molliver, D. C., Cook, S. P., Carlsten, J. A., Wright, D. E. & McCleskey, E. W. (2002) Eur. J. Neurosci. 16, 1850-1860.
20. Akassoglou, K., Yu, W. M., Akpinar, P. & Strickland, S. (2002) Neuron 33, 861-875.
21. Cressman, V. L., Lazarowski, E., Homolya, L., Boucher, R. C., Koller, B. H. & Grubb, B. R. (1999) J. Biol. Chem. 274, 26461-26468.
22. Taupenot, L., Mahata, M., Mahata, S. K. & O'Connor, D. T. (1999) Hypertension 34, 1152-1162.
23. Cosgaya, J. M., Chan, J. R. & Shooter, E. M. (2002) Science 298, 1245-1248.
24. Aoki, K., Nakamura, T. & Matsuda, M. (2004) J. Biol. Chem. 279, 713-719.
25. Bareyre, F. M., Kerschensteiner, M., Raineteau, O., Mettenleiter, T. C., Weinmann, O. & Schwab, M. E. (2004) Nat. Neurosci. 7, 269-277.
26. Park, K. I., Teng, Y. D. & Snyder, E. Y. (2002) Nat. Biotechnol. 20, 1111-1117.
27. D'Ambrosi, N., Murra, B., Cavaliere, F., Amadio, S., Bernardi, G., Burnstock, G. & Volonte, C. (2001) Neuroscience 108, 527-534.
28. Smeyne, R. J., Klein, R., Schnapp, A., Long, L. K., Bryant, S., Lewin, A., Lira, S. A. & Barbacid, M. (1994) Nature 368, 246-249.
29. Sanada, M., Yasuda, H., Omatsu-Kanbe, M., Sango, K., Isono, T., Matsuura, H. & Kikkawa, R. (2002) Neuroscience 111, 413-422.
30. Tuttle, R. & O'Leary, D. D. (1998) Mol. Cell. Neurosci. 11, 1-8.
31. Adler, J. E., Kessler, J. A. & Black, I. B. (1984) Dev. Biol. 102, 417-425.
32. Lindsay, R. M. (1988) J. Neurosci. 8, 2394-2405.
33. MacInnis, B. L., Senger, D. L. & Campenot, R. B. (2003) Neuropharmacology 45, 995-1010.
34. Xie, Y., Tisi, M. A., Yeo, T. T. & Longo, F. M. (2000) J. Biol. Chem. 275, 29868-29874.
35. Behrsing, H. P. & Vulliet, P. R. (2004) J. Neurosci. Res. 78, 64-74.
36. Vollmayer, P., Koeh, M., Braun, N., Heine, P., Servos, J., Israr, E., Kegel, B. & Zimmermann, H. (2001) J. Neurochem. 78, 1019-1028.
37. Joseph, S. M., Buchakjian, M. R. & Duhyak, G. R. (2003) J. Biol. Chem. 278, 23331-23342.
38. Sesti, C., Broekman, M. J., Drosopoulos, J. H., Islam, N., Marcus, A. J. & Levi, R. (2002) J. Pharmacol. Exp. Ther. 300, 605-611.
39. Schwann, T. A., Lobdell, K. W., Braxton, J., Condos, S., Baldwin, J. C. & Kopf, G. S. (1994) J. Surg. Res. 56, 356-360.
40. Delcroix, J. D., Patel, J., Averill, S., Tomlinson, D. R., Priestley, J. V. & Fernyhough, P. (2003) Neurosci. Lett. 351, 181-185.
41. Verge, V. M., Tetzlaff, W., Richardson, P. M. & Bishy, M. A. (1990)J. Neurosci. 10, 926-934.
42. Van der Zee, C. E., Nielander, H. B., Vos, J. P., Lopes da Silva, S., Verbaagen, J., Oestreicher, A. B., Schrama, L. H., Schotman, P. & Gispen, W. H. (1989) J. Neurosci. 9, 3505-3512.
43. Strittmatter, S. M., Fankhauser, C., Huang, P. L., Mashimo, H. & Fishman, M. C. (1995) Cell 80, 445-452.
44. Martin-Zanca, D., Barbacid, M. & Parada, L. F. (1990) Genes Dev. 4, 683-694.
45. Cheung, K. K., Ryten, M. & Burnstock, G. (2003) Dev. Dyn. 228, 254-266.
46. Broekhaus, J., Dressel, D., Herold, S. & Deitmer, J. W. (2004) Eur. J. Neurosci. 19, 2221-2230.
47. Newman, E. A. (2003) J. Neurosci. 23, 1659-1666.
48. Moore, D. J., Chambers, J. K., Wahlin, J. P., Tan, K. B., Moore, G. B., Jenkins, O., Emson, P. C. & Murdock, P. R. (2001) Biochim. Biophys. Acta. 1521, 107-119.
49. Koles, L., Furst, S. & Illes, P. (2005) Drug News Perspect. 18, 85-101.
50. Kim, L., Harwood, A. & Kimmel, A. R. (2002) Dev. Cell 3, 523-532.
51. Braun, N., Sevigny, J., Mishra, S. K., Robson, S. C., Barth, S. W., Gerstberger, R., Hammer, K. & Zimmermann, H. (2003) Eur. J. Neurosci. 17, 1355-1364.
52. Braun, N., Sevigny, J., Robson, S. C., Hammer, K., Hanani, M. & Zimmermann, H. (2004) Glia 45, 124-132.
53. Burnstock, G. & Williams, M. (2000) Perspect. Pharmacol. 295, 862-869.
54. Neary, J. T. & Kang, Y. (2005) Mol. Neurobiol. 31, 95-103.
55. Snider, W. D. (1994) Cell 77, 627-638.
56. Arslan, G., Filipeanu, C. M., Irenius, E., Kull, B., Clementi, E., Allgaier, C., Erlinge, D. & Fredholm, B. B. (2000) Neuropharmacology 39, 482-496.
57. Bouschet, T., Perez, V., Fernandez, C., Bockaert, J., Eychene, A. & Journot, L. (2003) J. Biol. Chem. 278, 4778-4785.
58. Lee, F. S. & Chao, M. V. (2001) Proc. Natl. Acad. Sci. USA 98, 3555-3560.